Is possible to rule out clinically significant prostate cancer using PI-RADS v2 for the assessment of prostate MRI?

OBJECTIVES: To evaluate the diagnostic performance and interobserver agreement of PI-RADS v2. MATERIALS AND METHODS: In this Institutional Review Board approved single-center retrospective study, 98 patients with clinically suspected PCa who underwent 3-T multiparametric MRI followed by MRI/TRUS fus...

Descripción completa

Detalles Bibliográficos
Autores principales: Viana, Publio Cesar Cavalcanti, Horvat, Natally, dos Santos, Valter Ribeiro, Lima, Thais Carneiro, Romão, Davi dos Santos, Cerri, Luciana Mendes de Oliveira, de Castro, Marilia Germanos, Vargas, Herbert Alberto, Miranda, Júlia Azevedo, Leite, Claudia da Costa, Cerri, Giovanni Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Urologia 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837601/
https://www.ncbi.nlm.nih.gov/pubmed/31136114
http://dx.doi.org/10.1590/S1677-5538.IBJU.2018.0382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837601/
https://www.ncbi.nlm.nih.gov/pubmed/31136114
http://dx.doi.org/10.1590/S1677-5538.IBJU.2018.0382

Ejemplares similares